Skip to main content

Advertisement

Log in

First Isolation of Candida dubliniensis from Oral Cavities of Dermatological Patients in Nanjing, China

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Candida dubliniensis is an emerging pathogen capable of causing both superficial and systemic infections. Although C. dubliniensis and C. albicans are phenotypically similar, the two species differ in terms of epidemiology and the ability to rapidly develop resistance to fluconazole. C. dubliniensis is primarily associated with oral candidiasis of human immunodeficiency virus (HIV)-infected individuals. In this study, we describe the first recovery of C. dubliniensis from oral cavities of non-HIV-infected patients with dermatological diseases in Nanjing, China. The isolates were phenotypically characterized as C. dubliniensis by their production of brown rough colonies and chlamydospores on tobacco agar and their inability to grow on hypertonic Sabouraud dextrose agar or to assimilate xylose or α-methyl-d-glycoside. The species identification was subsequently confirmed by amplification and sequencing of the internal transcribed spacer region (ITS). Three C. dubliniensis isolates out of 128 (2.3%) presumptive C. albicans/C. dubliniensis ones were finally identified. Further sequence analysis separated the three isolates into two of the four reported ITS genotypes. Antifungal susceptibility testing showed that they were susceptible to fluconazole, itraconazole, voriconazole, micafungin, and amphotericin B. This study adds to the accumulating evidence that C. dubliniensis is widely distributed in non-HIV-infected populations worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Coleman DC, Rinaldi MG, Haynes KA, Rex JH, Summerbell RC, Annaissie EJ, Li A, Sullivan DJ. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med Mycol. 1998;36(Suppl 1):156–65.

    PubMed  Google Scholar 

  2. Sullivan DJ, Westerneng TJ, Haynes KA, Bennet DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 1995;141:1507–21.

    Article  PubMed  CAS  Google Scholar 

  3. Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington B, Shanley DB, Coleman DC. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother. 1997;41:617–23.

    PubMed  CAS  Google Scholar 

  4. Jabra-Rizk MA, Falkler WA Jr, Merz WG, Baqui AAMA, Kelly JI, Meiller TF. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microbiol. 2000;38:2423–6.

    PubMed  CAS  Google Scholar 

  5. Odds FC, Van Nuffel L, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol. 1998;36:2869–73.

    PubMed  CAS  Google Scholar 

  6. Meis JF, Ruhnke M, DePauw BE, Odds FC, Siegert W, Verweij PE. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis. 1999;5:150–3.

    Article  PubMed  CAS  Google Scholar 

  7. Redding SW, Zellars RC, Kirkpatrick WR, et al. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol. 1999;37:3896–900.

    PubMed  CAS  Google Scholar 

  8. Polacheck I, Strahilevitz J, Sullivan DJ, Donnelly S, Salkin IF, Coleman DC. Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol. 2000;38:170–4.

    PubMed  CAS  Google Scholar 

  9. Manfredi M, McCullough MJ, Al-Karaawi ZM, Hurel SJ, Porter SR. The isolation, identification and molecular analysis of Candida spp. isolated from the oral cavities of patients with diabetes mellitus. Oral Microbiol Immunol. 2002;17:181–5.

    Article  PubMed  CAS  Google Scholar 

  10. Fotedar R, Al Hedaithy SSA. Candida dubliniensis at a University Hospital in Saudi Arabia. J Clin Microbiol. 2003;41:1907–11.

    Article  PubMed  CAS  Google Scholar 

  11. Ahmad S, Khan Z, Mokaddas E, Khan ZU. Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J Med Microbiol. 2004;53:633–7.

    Article  PubMed  CAS  Google Scholar 

  12. Jabra-Rizk MA, Johnson JK, Forrest G, Mankes K, Meiller TF, Venezia RA. Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin Infect Dis. 2005;41:1064–7.

    Article  PubMed  Google Scholar 

  13. Jewtuchowicz VM, Mujica MT, Brusca MI, Sordelli N, Malzone MC, Pola SJ, Iovannitti CA, Rosa AC. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina. Oral Microbiol Immunol. 2008;23:505–9.

    Article  PubMed  CAS  Google Scholar 

  14. Moran GP, Sanglard D, Donnelly SM, Shanley DB, Sullivan DJ, Coleman DC. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother. 1998;42:1819–30.

    PubMed  CAS  Google Scholar 

  15. Sullivan DJ, Coleman DC. Candida dubliniensis: characteristics and identification. J Clin Microbiol. 1998;36:329–34.

    PubMed  CAS  Google Scholar 

  16. Al-Mosaid A, Sullivan DJ, Salkin IF, Shanley D, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol. 2001;39:323–7.

    Article  PubMed  CAS  Google Scholar 

  17. Al-Mosaid A, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Pal’s agar. J Clin Microbiol. 2003;41:4787–9.

    Article  PubMed  Google Scholar 

  18. Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, Soll DR. Identification of Candida dubliniensis based on temperature and utilization of xylose and α-methyl-d-glucoside as determined with the API 20C AUX and Vitek YBC systems. J Clin Microbiol. 1999;37:3804–8.

    PubMed  CAS  Google Scholar 

  19. Khan ZU, Ahmad S, Mokaddas E, Chandy R. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol. 2004;42:4796–8.

    Article  PubMed  Google Scholar 

  20. Kirkpatric WR, Revankar SG, McAtee RK, López-Ribot JL, Fothergill AW, McCarthy DI, Sanche SE, Cantu RA, Rinaldi MG, Patterson TF. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol. 1998;36:3007–12.

    Google Scholar 

  21. Akgül O, Cerikçioğlu N. Hypertonic Sabouraud dextrose agar as a substrate for differentiation of Candida dubliniensis. Mycopathologia. 2009;167:357–9.

    Article  PubMed  Google Scholar 

  22. White TJ, Bruns TD, Lee SB, Taylor JW. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press; 1990. p. 315–22.

    Google Scholar 

  23. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–9.

    Article  PubMed  CAS  Google Scholar 

  24. CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts. 3rd ed. Approved standard M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.

  25. Gutierrez J, Morales P, Gonzalez MA, Quindos G. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol. 2002;42:207–27.

    Article  PubMed  CAS  Google Scholar 

  26. Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, Coleman DC. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res. 2004;4:369–76.

    Article  PubMed  CAS  Google Scholar 

  27. Gee SF, Joly S, Soll DR, Meis JF, Verweij PE, Polacheck I, Sullivan DJ, Coleman DC. Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J Clin Microbiol. 2002;40:556–74.

    Article  PubMed  CAS  Google Scholar 

  28. Quindos G, Carrillo-Munoz AJ, Arevalo MP, et al. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Chemotherapy. 2000;46:395–401.

    Article  PubMed  CAS  Google Scholar 

  29. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA, The Global Antifungal Surveillance Group. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48:1366–77.

    Article  PubMed  CAS  Google Scholar 

  30. Kim TH, Park BG, Kim HR, Lee MK. Candida dubliniensis screening using the germ tube test in clinical yeast isolates, prevalence of C. dubliniensis in Korea. J Clin Lab Anal. 2010;24:145–8.

    Article  PubMed  CAS  Google Scholar 

  31. Qin ZY, Wu SX, Tan SH, Lu GX, Chen W, Tang NF, Guo NR. The first isolation of Candida dubliniensis from China [in Chinese]. J Clin Dermatol. 1999;4:213–4.

    Google Scholar 

  32. Tamura M, Watanabe K, Imai T, Mikami Y, Nishimura K. New PCR primer pairs specific for Candida dubliniensis and detection of the fungi from the Candida albicans clinical isolates in Japan. Clin Lab. 2000;46:33–40.

    PubMed  CAS  Google Scholar 

  33. Wang HP, Tian JQ, Ma HJ. Isolation and drug sensitivity test of vaginal Candida dubliniensis [in Chinese]. Chin J Lep Skin Dis. 2005;21:364–6.

    Google Scholar 

  34. Wang LW, Chen MH, Sun YT. Identification and methodology of Candida dubliniensis [in Chinese]. Chin J Healt Lab Tech. 2003;2:152–3.

    Google Scholar 

  35. Yang M, Xu PP, Dong JY, et al. Frequency and species distribution of Candida in oral cavity of human immunodeficiency virus-infected patients [in Chinese]. J Pract Med. 2009;9:1384–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wei D. Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ge, Y.P., He, G.X., Lin, T. et al. First Isolation of Candida dubliniensis from Oral Cavities of Dermatological Patients in Nanjing, China. Mycopathologia 172, 465–471 (2011). https://doi.org/10.1007/s11046-011-9447-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-011-9447-1

Keywords

Navigation